High-grade Fallopian Tube Serous Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-05-13
Clinical Trial Update: Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC) [Phase 1, Phase 2]
Clinical trial update indicates the Phase 1/2 study of birinapant in combination with carboplatin for recurrent high-grade ovarian, fallopia…